Last 68.00 INR
Change Today 0.00 / 0.00%
Volume 0.0
JBP On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:00 AM 05/23/13 All times are local (Market data is delayed by at least 15 minutes).

jenburkt pharmaceuticals (JBP) Snapshot

Open
68.00
Previous Close
68.00
Day High
68.00
Day Low
68.00
52 Week High
07/4/12 - 82.70
52 Week Low
08/31/12 - 59.00
Market Cap
316.2M
Average Volume 10 Days
1.1K
EPS TTM
12.89
Shares Outstanding
4.6M
EX-Date
07/23/12
P/E TM
5.3x
Dividend
3.50
Dividend Yield
5.15%
Current Stock Chart for JENBURKT PHARMACEUTICALS (JBP)

Related News

No related news articles were found.

jenburkt pharmaceuticals (JBP) Related Businessweek News

No Related Businessweek News Found

jenburkt pharmaceuticals (JBP) Details

Jenburkt Pharmaceuticals Ltd. engages in the manufacture and marketing of pharmaceutical formulations and healthcare products in India. It offers anti-arthritic; antibiotic; anti-diabetic; nutraceutical; anti-inflammatory analgesic; gastro intestinal; dermatological; aphrodisiac; anti-osteoporotic; anti-cough, cold, and allergy; and anti-ulcerant drugs. The company provides its products to doctors and chemist/retailers, as well as to government, semi-government institutions, missionary hospitals, and public sector enterprises. Jenburkt Pharmaceuticals Ltd. also exports its products to Asian and African countries. The company was founded in 1985 and is headquartered in Mumbai, India.

Founded in 1985

jenburkt pharmaceuticals (JBP) Top Compensated Officers

Chairman, Managing Director and Member of Sha...
Total Annual Compensation: 3.0M
Whole Time Director
Total Annual Compensation: 5.2M
Compensation as of Fiscal Year 2012.

jenburkt pharmaceuticals (JBP) Key Developments

Jenburkt Pharmaceuticals Ltd. Appoints Ashish U. Bhuta as Whole Time Director

Jenburkt Pharmaceuticals Ltd. announced at its Board meeting held on February 14, 2013, has appointed Ashish U. Bhuta as Whole Time Director.

Jenburkt Pharmaceuticals Ltd. Approves Amendments to Memorandum and Articles of Association

Jenburkt Pharmaceuticals Ltd. announced that the board has approved to alter the Clause V of Memorandum and Clause 5 of articles of association of the company and to alter the main object clause and other objects clause of the memorandum of association of the company at its meeting to be held on February 14, 2013.

Jenburkt Pharmaceuticals Ltd. Recommends Alteration of Memorandum and Articles of Association

Jenburkt Pharmaceuticals Ltd. announced that the board has recommended alteration of memorandum and articles of association of the company at its meeting to be held on February 14, 2013.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JBP:IN 68.00 INR 0.00

JBP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for JBP.
View Industry Companies
 

Industry Analysis

JBP

Industry Average

Valuation JBP Industry Range
Price/Earnings 5.0x
Price/Sales 0.5x
Price/Book -- Not Meaningful
Price/Cash Flow 4.2x
TEV/Sales -- Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JENBURKT PHARMACEUTICALS, please visit www.jenburkt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.